Alentemol

Alentemol
Names
	IUPAC name 2-(Dipropylamino)-2,3-dihydro-1H-phenalen-5-ol
Identifiers
CAS Number	112891-97-1 ;
3D model (JSmol)	Interactive image;
ChEMBL	ChEMBL2104081;
ChemSpider	54603;
PubChem CID	60574;
UNII	F6S91MHL3E ;
CompTox Dashboard (EPA)	DTXSID80869556 ;
	InChI InChI=1S/C19H25NO/c1-3-8-20(9-4-2)17-10-14-6-5-7-15-12-18(21)13-16(11-17)19(14)15/h5-7,12-13,17,21H,3-4,8-11H2,1-2H3 Key: TWUJBHBRYYTEDL-UHFFFAOYSA-N; InChI=1/C19H25NO/c1-3-8-20(9-4-2)17-10-14-6-5-7-15-12-18(21)13-16(11-17)19(14)15/h5-7,12-13,17,21H,3-4,8-11H2,1-2H3 Key: TWUJBHBRYYTEDL-UHFFFAOYAC;
	SMILES CCCN(CCC)C1CC2=CC=CC3=CC(=CC(=C23)C1)O;
Properties
Chemical formula	C19H25NO
Molar mass	283.415 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Alentemol (INN) (developmental code name U-66444B), or alentamol, is a selective dopamine autoreceptor agonist described as an antipsychotic, which was never marketed.^[1]^[2]

References

^ William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 143–. ISBN 978-0-8155-1856-3.
^ A.F. Casy (11 November 2013). The Steric Factor in Medicinal Chemistry: Dissymmetric Probes of Pharmacological Receptors. Springer Science & Business Media. pp. 178–. ISBN 978-1-4899-2397-4.

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

[Publishing2013-1] William Andrew Publishing (22 October 2013). Pharmaceutical Manufacturing Encyclopedia, 3rd Edition. Elsevier. pp. 143–. ISBN 978-0-8155-1856-3.

[Casy2013-2] A.F. Casy (11 November 2013). The Steric Factor in Medicinal Chemistry: Dissymmetric Probes of Pharmacological Receptors. Springer Science & Business Media. pp. 178–. ISBN 978-1-4899-2397-4.

[1]

[2]

v t e Antipsychotics (N05A)
Typical	Butyrophenones: Benperidol Bromperidol Bromperidol decanoate Droperidol Haloperidol^# Haloperidol decanoate Moperone Pipamperone Spiperone Timiperone Trifluperidol Diphenylbutylpiperidines: Fluspirilene Penfluridol Pimozide Phenothiazines: Acepromazine Acetophenazine Butaperazine Carphenazine (carfenazine)^‡ Chlorpromazine Cyamemazine Dixyrazine Fluphenazine Fluphenazine decanoate Fluphenazine enanthate Levomepromazine (methotrimeprazine) Mesoridazine Perazine Periciazine Perphenazine BL-1020 Perphenazine decanoate Perphenazine enanthate Piperacetazine Pipotiazine Pipotiazine palmitate Pipotiazine undecylenate Prochlorperazine Promazine Sulforidazine Thiopropazate Thioproperazine Thioridazine Trifluoperazine Triflupromazine Thioxanthenes: Chlorprothixene Clopenthixol Clopenthixol decanoate Flupentixol Flupentixol decanoate Tiotixene (thiothixene) Zuclopenthixol Zuclopenthixol acetate Zuclopenthixol decanoate
Disputed	Benzamides: Amisulpride Levosulpiride Nemonapride Remoxipride^‡ Sulpiride Sultopride Tiapride Veralipride^‡ Butyrophenones: Melperone Tricyclics: Carpipramine Clocapramine Clorotepine Clotiapine Loxapine Mosapramine Oxyprothepin decanoate Others: Molindone
Atypical	Benzisoxazole/benzisothiazoles: Iloperidone Lurasidone Paliperidone Paliperidone palmitate Perospirone Risperidone^# Ziprasidone Butyrophenones: Lumateperone Phenylpiperazines/quinolinones: Aripiprazole Aripiprazole lauroxil Brilaroxazine^† Brexpiprazole Cariprazine Tricyclics: Asenapine Clozapine^# Olanzapine (+samidorphan) Quetiapine Zotepine Others: Blonanserin Pimavanserin Sertindole
Others	Monoamine-depleting agents: Oxypertine Reserpine Tetrabenazine Others/unknown: Azacyclonol Xanomeline/trospium chloride
^#WHO-EM ^‡Withdrawn from market Clinical trials: ^†Phase III ^§Never to phase III